# PRAMEF6

## Overview
PRAMEF6, or Preferentially Expressed Antigen in Melanoma Family Member 6, is a gene that encodes a protein belonging to the PRAME family, which is characterized by leucine-rich repeat (LRR) domains. These domains are known for facilitating protein-protein interactions, suggesting the protein's involvement in complex cellular signaling pathways (Kern2021The). The PRAMEF6 protein functions as a substrate receptor for the CRL2 ubiquitin ligase complex, playing a critical role in protein quality control by targeting defective selenoproteins for degradation (Lin2015CRL2). Expressed predominantly in reproductive tissues and early embryonic stages, PRAMEF6 is implicated in reproductive processes and early development (Kern2021The). Additionally, PRAMEF6 is part of the cancer-testis antigen group, with its expression linked to various cancers, making it a potential marker for cancer prognosis (Kern2021The).

## Function
PRAMEF6 is a member of the PRAME gene family, which is involved in various cellular processes, including protein degradation and reproductive functions. In healthy human cells, PRAMEF6 functions as a substrate receptor for the CRL2 ubiquitin ligase complex, which is responsible for the degradation of truncated selenoproteins. This process is crucial for maintaining protein quality control by eliminating defective translational products that result from unsuccessful UGA to Sec decoding, thereby preventing potential cellular damage (Lin2015CRL2).

PRAMEF6 is expressed in reproductive tissues such as the testis, ovary, oocytes, zygote, and early embryonic stages, suggesting a role in reproductive processes and early development (Kern2021The). The PRAME family proteins, including PRAMEF6, are characterized by leucine-rich repeat (LRR) domains, which facilitate protein-protein interactions, indicating their involvement in complex cellular signaling pathways (Kern2021The). Although the specific molecular functions of PRAMEF6 in cell biology are not fully detailed, its expression pattern and structural features suggest it plays a role in cellular differentiation and development, particularly in the context of reproduction and early embryogenesis (Kern2021The).

## Clinical Significance
PRAMEF6, a member of the PRAME gene family, has been implicated in various cancer-related conditions. It is part of a group of cancer-testis antigens (CTAs) that are predominantly expressed in the testis and various tumors, making it a potential marker for cancer prognosis (Kern2021The). In oral squamous cell carcinoma (OSCC), PRAMEF6 is significantly enriched in cases with perineural invasion (PNI), suggesting its role in the progression and prognosis of this cancer type (Kuk2024Prognostic). The gene has also been identified in papillary renal cell carcinoma (PRCC) and its precursor lesions, indicating a potential role in tumorigenesis through shared mutational pathways (Saleeb2019Integrated).

While specific diseases directly caused by PRAMEF6 mutations are not detailed, its expression and mutation patterns are associated with cancer development and progression. The gene's involvement in oncogenesis is supported by its expression in tumors and its potential impact on tumor growth and immune evasion (Kern2021The). These findings highlight the clinical significance of PRAMEF6 in cancer biology, although further research is needed to fully elucidate its role in specific diseases.


## References


[1. (Lin2015CRL2) Hsiu-Chuan Lin, Szu-Chi Ho, Yi-Yun Chen, Kay-Hooi Khoo, Pang-Hung Hsu, and Hsueh-Chi S. Yen. Crl2 aids elimination of truncated selenoproteins produced by failed uga/sec decoding. Science, 349(6243):91–95, July 2015. URL: http://dx.doi.org/10.1126/science.aab0515, doi:10.1126/science.aab0515. This article has 57 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.aab0515)

[2. (Kuk2024Prognostic) Su Kyung Kuk, Kitae Kim, Jae Il Lee, and KangMi Pang. Prognostic dna mutation and mrna expression analysis of perineural invasion in oral squamous cell carcinoma. Scientific Reports, January 2024. URL: http://dx.doi.org/10.1038/s41598-024-52745-6, doi:10.1038/s41598-024-52745-6. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-024-52745-6)

[3. (Kern2021The) Chandlar H Kern, Mingyao Yang, and Wan-Sheng Liu. The prame family of cancer testis antigens is essential for germline development and gametogenesis. Biology of Reproduction, 105(2):290–304, April 2021. URL: http://dx.doi.org/10.1093/biolre/ioab074, doi:10.1093/biolre/ioab074. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/biolre/ioab074)

[4. (Saleeb2019Integrated) Rola M. Saleeb, Mina Farag, Qiang Ding, Michelle Downes, Georg Bjarnason, Fadi Brimo, Pamela Plant, Fabio Rotondo, Zsuzsanna Lichner, Antonio Finelli, and George M. Yousef. Integrated molecular analysis of papillary renal cell carcinoma and precursor lesions unfolds evolutionary process from kidney progenitor-like cells. The American Journal of Pathology, 189(10):2046–2060, October 2019. URL: http://dx.doi.org/10.1016/j.ajpath.2019.07.002, doi:10.1016/j.ajpath.2019.07.002. This article has 10 citations.](https://doi.org/10.1016/j.ajpath.2019.07.002)